European Pharmacopoeia

The implementation date for the 8th Edition is 1 January 2014 and this edition will, over the next 3 years, be augmented with 8 supplements containing the texts adopted at the sessions of the European Pharmacopoeia Commission. As ever, it is published in the 2 official languages of the Council of...

United States Pharmacopoeia

USP–NF is published in continuing pursuit of the mission of USP: To improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.This section provides background information on the United States Pharmacopeial Conventi...

British Pharmacopoeia

The British Pharmacopoeia (BP) is the official collection of standards for UK medicinal products and pharmaceutical substances. Produced by the British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare Products Regulatory Agency, the BP makes an important contribution to public...

International Pharmacopoeia

Japanese Pharmacopoeia

The 15th Edition of the Japanese Pharmacopoeia (JP) was promulgated by Ministerial Notification No.285 of the Ministry of Health, Labour and Welfare (MHLW) on March 31, 2006.In July 2006, the Committee on JP established the basic principles for the preparation of the JP 16th Edition, setting out ...